Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

GNL3L Activators

Compounds that influence cyclic nucleotide levels in cells have a profound impact on nucleolar activities and are therefore key in modulating the functional activity of GNL3L. The enhancement of intracellular cAMP through direct stimulation of adenylyl cyclase or inhibition of phosphodiesterases results in a cascade of events that bolster the nucleolar functions of GNL3L. This is achieved by promoting ribosomal biogenesis and protein synthesis, core processes that are fundamental to the role of GNL3L in the cell. Membrane-permeable analogs of cAMP also contribute to this activation by mimicking the natural ligand and engaging the same pathways, thus providing a sustained activation signal to GNL3L. In a similar vein, the elevation of cGMP levels through the activation of soluble guanylyl cyclase or the inhibition of specific phosphodiesterases can indirectly enhance GNL3L activity. The precise modulation of GNL3L activity within the nucleolus is critical for maintaining cellular homeostasis and ensuring efficient ribosome biogenesis.

The intricate network of protein-protein interactions within the nucleus is also crucial for the regulation of GNL3L. Stabilization of these interactions, specifically involving 14-3-3 proteins and their phosphorylated partners, results in an indirect upregulation of GNL3L's involvement in nucleolar functions. The increased availability of cyclic nucleotides due to the inhibition of various phosphodiesterases further underscores the importance of these small molecules in the indirect activation of GNL3L. By influencing the levels of cAMP and cGMP, these compounds fine-tune the cellular signaling pathways that ultimately dictate the activity of GNL3L.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Directly stimulates adenylyl cyclase, increasing intracellular cAMP levels which may enhance GNL3L activity by promoting ribosomal biogenesis and protein synthesis.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Selective inhibitor of phosphodiesterase 4, elevating cAMP levels, thereby potentially enhancing GNL3L function in nucleolar processes.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor, increases cAMP by preventing its breakdown, which could enhance GNL3L activity through cAMP-mediated signaling pathways.

Fusicoccin

20108-30-9sc-200754
sc-200754A
sc-200754B
1 mg
5 mg
10 mg
$416.00
$2081.00
$4162.00
7
(1)

Stabilizes the interaction between 14-3-3 proteins and phosphorylated partners, potentially enhancing GNL3L activity via protein-protein interactions within the nucleus.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

A membrane-permeable cAMP analog that activates cAMP-dependent pathways, possibly leading to increased GNL3L function related to nucleolar activity.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Phosphodiesterase 3 inhibitor that raises cAMP levels, potentially contributing to GNL3L activation within its role in the nucleolus.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Phosphodiesterase 5 inhibitor, increases cAMP and cGMP levels, which may indirectly activate GNL3L by influencing signaling pathways involved in nucleolar functions.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

A phosphodiesterase 1 inhibitor that augments cAMP and cGMP levels, potentially enhancing GNL3L activity involved in ribosome biogenesis.

YC-1

170632-47-0sc-202856
sc-202856A
sc-202856B
sc-202856C
1 mg
5 mg
10 mg
50 mg
$33.00
$124.00
$218.00
$947.00
9
(1)

Increases cGMP levels by activating soluble guanylyl cyclase, which may indirectly enhance GNL3L activity involved in the regulation of nucleolar processes.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

A selective phosphodiesterase 3 inhibitor which increases cAMP levels, possibly contributing to enhanced GNL3L activity within its roles in the nucleolus.